146 related articles for article (PubMed ID: 10492142)
21. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
[TBL] [Abstract][Full Text] [Related]
22. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
23. Doppler ultrasonography for the assessment of tumor necrosis after percutaneous ethanol injection prior to liver transplantation as adjuvant therapy of hepatocellular carcinoma.
Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Bustamante M; Martinez J; Segade FR; Conde R; Varo E
Transplant Proc; 2005 Apr; 37(3):1493-5. PubMed ID: 15866652
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma: CT appearance of parenchymal changes after percutaneous ethanol injection therapy.
Yoshikawa J; Matsui O; Kadoya M; Gabata T; Miyayama S; Takahashi S; Takashima T; Kobayashi K
Radiology; 1995 Jan; 194(1):107-11. PubMed ID: 7997535
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306
[TBL] [Abstract][Full Text] [Related]
26. Response of hepatocellular carcinoma to percutaneous ethanol injection: CT and MR evaluation.
Lencioni R; Caramella D; Bartolozzi C
J Comput Assist Tomogr; 1993; 17(5):723-9. PubMed ID: 8396598
[TBL] [Abstract][Full Text] [Related]
27. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
29. Human aldolase B serum levels: a marker of liver injury.
Asaka M; Miyazaki T; Hollinger FB; Alpert E
Hepatology; 1984; 4(3):531-5. PubMed ID: 6724519
[TBL] [Abstract][Full Text] [Related]
30. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
Ebara M; Kita K; Nagato Y; Yoshikawa M; Sugiura N; Ohto M
Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
[TBL] [Abstract][Full Text] [Related]
31. [Determination of aldolase A by radioimmunoassay. Experimental and clinical studies on the diagnosis of cancer of the digestive tract].
Tanaka H
Hokkaido Igaku Zasshi; 1983 Jul; 58(4):363-75. PubMed ID: 6313505
[TBL] [Abstract][Full Text] [Related]
32. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation.
Kawamura R; Seki T; Umehara H; Ikeda K; Inokuchi R; Asayama T; Yamaguchi T; Takahashi Y; Sakao M; Lencioni R; Okazaki K
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):325-33. PubMed ID: 21607824
[TBL] [Abstract][Full Text] [Related]
35. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
36. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
37. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
38. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Collazos J
Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
[No Abstract] [Full Text] [Related]
39. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?
Feier D; Lupsor Platon M; Stefanescu H; Badea R
J Gastrointestin Liver Dis; 2013 Sep; 22(3):283-9. PubMed ID: 24078985
[TBL] [Abstract][Full Text] [Related]
40. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Yao FY
Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
